Berlin A, Dahlström H
Eur J Clin Pharmacol. 1975 Dec 19;9(2-3):155-9. doi: 10.1007/BF00614012.
Eight healthy volunteers were given single i.v. and oral doses of clonazepam (2 mg). The disposition curves after i.v. administration showed a biexponential decline and the data were applied to a two-compartment open model. The volume of distribution ((Vd)beta) ranged between 1.5 and 4.4 l/kg and the plasma half-life (t1/2) between 19 and 60 hours. Absorption after oral administration was fast, with peak plasma concentrations within 4 hours in all subjects. Five of the subjects received repeated oral doses of clonazepam 0.5 mg bid for 15 days. The plasma level during steady state (estimated as Cmin within the dose interval) could be predicted from the constants A, B, alpha and beta obtained in the single dose study with a coefficient of variation of 6%. The plasma half-lives after cessation of the subchronic dosing were of the same magnitude as after single doses.
八名健康志愿者接受了单次静脉注射和口服氯硝西泮(2毫克)。静脉注射后的处置曲线呈双指数下降,并将数据应用于二室开放模型。分布容积((Vd)β)在1.5至4.4升/千克之间,血浆半衰期(t1/2)在19至60小时之间。口服给药后吸收迅速,所有受试者在4小时内达到血浆峰值浓度。五名受试者接受了氯硝西泮0.5毫克每日两次的重复口服给药,持续15天。稳态期间的血浆水平(估计为剂量间隔内的Cmin)可以根据单剂量研究中获得的常数A、B、α和β预测,变异系数为6%。亚慢性给药停止后的血浆半衰期与单次给药后的半衰期相同。